NCT03912649 (REVALID03) is a NA clinical trial of RemovAid in Removal Contraceptive Implant, sponsored by RemovAid AS.

Who is sponsoring NCT03912649?

NCT03912649 is sponsored by RemovAid AS.

What drugs are being tested in NCT03912649?

Interventions in NCT03912649: RemovAid.

What condition does NCT03912649 study?

NCT03912649 studies Removal Contraceptive Implant.

Is NCT03912649 still recruiting?

NCT03912649 is currently terminated. Last updated 3 February 2021.

Last reviewed 2021-02-03 · How we verify

NCT03912649: REVALID03

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation to Evaluate Performance and Safety of RemovAid ™ in Removal of Contraceptive Implants

Terminated NA Last updated 3 February 2021

What this trial tests

NA trial testing RemovAid in Removal Contraceptive Implant in 15 participants. Terminated before completion.

Timeline

11 June 2019

Primary endpoint
18 November 2020

18 November 2020

Quick facts

Lead sponsor	RemovAid AS
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	11 June 2019
Primary completion	18 November 2020
Estimated completion	18 November 2020
Sites	1 location across Sweden

Drugs / interventions tested

RemovAid

Conditions studied

Removal Contraceptive Implant — all drugs for Removal Contraceptive Implant →

Sponsor

RemovAid AS

Who can join

Adults 18 to 99, female only, with Removal Contraceptive Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The safety and efficacy of a subdermal implant retrieval device (RemovAid) is investigated in a population of 25 women seeking removal of their palpable contraceptive implants. The primary endpoint of the device is to evaluate the performance of the device, specifically its success rate in removing palpable contraceptive implants. The device shall be able to fixate at least 80% of palpable implants, and successfully remove at least 90% of these implants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other RemovAid AS trials

Trials by the same sponsor.

NCT04120337 — Safe Access: Trial With RemovAid Device · NA · completed
NCT03356119 — Pilot Removal of Palpable Subdermal Contraceptive Rod Implants · NA · terminated
NCT02986971 — Removal of Palpable Subdermal Contraceptive Rod Implants. · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03912649 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RemovAid AS
Last refreshed: 3 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03912649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing